Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Rexahn, Vivus Believe the World Needs 2 More ED Drugs
- Two companies are developing new erectile dysfunction drugs, even though there's already three on the market and one of those -- Pfizer's Viagra -- is set to go generic between 2011 and 2013. Rexahn is developing a compound called Zoraxel and Vivus is developing Avanafil. Rexahn is...
- Blog posts 2009-02-12
Additional Resources
- Rexahn Awarded Maryland Industrial Partnerships Grant to Develop Targeted Nano-Polymer Cancer Drugs
- Company to Partner with University of Maryland to Develop Targeted Cancer Therapy ROCKVILLE, Md. -- Rexahn Pharmaceuticals (OTCBB:RXHN) today announced that it has been awarded a grant through the Maryland Industrial Partnerships Program MIPS. With the grant, researchers at Rexahn and the University of Maryland, Baltimore UMB Center for...
- Research articles 2007-03-06
- Rexahn and University of Maryland Nanomedicine Center Join to Develop Cancer and CNS Therapies; Company to Apply Nanotechnology to Drugs for More Potent Treatment and Efficient Delivery
- ROCKVILLE, Md. -- In a unique collaboration aimed at applying cutting edge nanotechnology to its product development, Rexahn Pharmaceuticals has partnered with the University of Maryland's Center for Nanomedicine and Cellular Delivery to develop cancer-fighting drugs and central nervous system therapies.
- Research articles 2006-02-23
- Lexicon Pharmaceuticals: Stuck in Phase II?
- VFC submits: Hi Vinny, I am a loyal follower and respect your opinion. I too am a long-term shareholder of CVM and see the potential of the company. That said, I wanted your opinion on two companies, of which I am already a shareholder, Lexicon Pharmaceuticals LXRX and Rexahn...
- External links 2009-11-11
- << Previous
- page 1 of 1
- Next >>
